ZA201301795B - Inhibitors of notum pectinacetylesterase and methods of their use - Google Patents

Inhibitors of notum pectinacetylesterase and methods of their use

Info

Publication number
ZA201301795B
ZA201301795B ZA2013/01795A ZA201301795A ZA201301795B ZA 201301795 B ZA201301795 B ZA 201301795B ZA 2013/01795 A ZA2013/01795 A ZA 2013/01795A ZA 201301795 A ZA201301795 A ZA 201301795A ZA 201301795 B ZA201301795 B ZA 201301795B
Authority
ZA
South Africa
Prior art keywords
inhibitors
methods
notum pectinacetylesterase
pectinacetylesterase
notum
Prior art date
Application number
ZA2013/01795A
Inventor
Joseph Barbosa
Kenneth Gordon Carson
Michael Walter Gardyan
Wei He
Victoria Lombardo
Praveen Pabba
Jr James Tarver
Original Assignee
Lexicon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lexicon Pharmaceuticals Inc filed Critical Lexicon Pharmaceuticals Inc
Publication of ZA201301795B publication Critical patent/ZA201301795B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2013/01795A 2010-09-14 2013-03-08 Inhibitors of notum pectinacetylesterase and methods of their use ZA201301795B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38252610P 2010-09-14 2010-09-14
PCT/US2011/051421 WO2012037141A1 (en) 2010-09-14 2011-09-13 Inhibitors of notum pectinacetylesterase and methods of their use

Publications (1)

Publication Number Publication Date
ZA201301795B true ZA201301795B (en) 2014-05-28

Family

ID=44678054

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2013/01795A ZA201301795B (en) 2010-09-14 2013-03-08 Inhibitors of notum pectinacetylesterase and methods of their use

Country Status (22)

Country Link
US (2) US20120065200A1 (en)
EP (1) EP2616471B1 (en)
JP (1) JP2013537202A (en)
KR (1) KR20130112888A (en)
CN (1) CN103328481A (en)
AR (1) AR082968A1 (en)
AU (1) AU2011302225A1 (en)
BR (1) BR112013006131A2 (en)
CA (1) CA2811005A1 (en)
CL (1) CL2013000682A1 (en)
CO (1) CO6710916A2 (en)
DK (1) DK2616471T3 (en)
ES (1) ES2536078T3 (en)
MX (1) MX2013002851A (en)
NZ (1) NZ608031A (en)
PL (1) PL2616471T3 (en)
PT (1) PT2616471E (en)
RU (1) RU2013116801A (en)
SG (1) SG188530A1 (en)
TW (1) TW201219401A (en)
WO (1) WO2012037141A1 (en)
ZA (1) ZA201301795B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933087B2 (en) 2010-07-23 2015-01-13 President And Fellows Of Harvard College Tricyclic proteasome activity enhancing compounds
AR090037A1 (en) * 2011-11-15 2014-10-15 Xention Ltd DERIVATIVES OF TIENO AND / OR FURO-PYRIMIDINES AND PYRIDINES INHIBITORS OF THE POTASSIUM CHANNELS
JP2015504919A (en) 2012-01-25 2015-02-16 プロテオステイシス セラピューティクス,インコーポレイテッド Compounds that modulate proteasome activity
CN110337437B (en) 2016-12-28 2023-02-03 达特神经科学有限公司 Substituted pyrazolopyrimidinones as PDE2 inhibitors
KR20200108419A (en) 2017-11-27 2020-09-18 다트 뉴로사이언스, 엘엘씨 Substituted furanopyrimidine compounds as PDE1 inhibitors
GB201814151D0 (en) 2018-08-31 2018-10-17 Ucl Business Plc Compounds
CN111171044B (en) * 2018-11-13 2022-06-24 沈阳化工研究院有限公司 Thienopyrimidine compound and medical application thereof
AR117472A1 (en) 2018-12-21 2021-08-11 Celgene Corp RIPK2 TIENOPYRIDINE INHIBITORS
CA3133100A1 (en) 2019-03-19 2020-09-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic aza-benzothiophene and aza-benzofuran compounds
JP2023528822A (en) 2020-05-29 2023-07-06 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド anthelmintic heterocyclic compound
WO2022251343A2 (en) * 2021-05-27 2022-12-01 National Health Research Institutes Cdgsh iron sulfur domain 2 activators and use thereof
WO2023073641A1 (en) 2021-11-01 2023-05-04 Boehringer Ingelheim Vetmedica Gmbh Anthelmintic pyrrolopyridazine compounds
CN114984188A (en) * 2022-06-20 2022-09-02 重庆医科大学 Application of NOTUM and BMP9 as combined target in osteogenic differentiation of cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4008726A1 (en) 1990-03-19 1991-09-26 Basf Ag Thieno-(2,3-D)pyrimidine derivs. - are plant growth regulators, herbicides and pesticides, esp. insecticides
US6080576A (en) 1998-03-27 2000-06-27 Lexicon Genetics Incorporated Vectors for gene trapping and gene activation
US6232320B1 (en) 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
JP2009539988A (en) * 2006-06-12 2009-11-19 バーテックス ファーマシューティカルズ インコーポレイテッド Thienopyrimidines useful as regulators of ion channels
WO2009001214A2 (en) * 2007-06-28 2008-12-31 Pfizer Products Inc. Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists

Also Published As

Publication number Publication date
SG188530A1 (en) 2013-04-30
KR20130112888A (en) 2013-10-14
RU2013116801A (en) 2014-10-20
PL2616471T3 (en) 2015-07-31
DK2616471T3 (en) 2015-04-07
AR082968A1 (en) 2013-01-23
US20140288071A1 (en) 2014-09-25
AU2011302225A1 (en) 2013-03-21
JP2013537202A (en) 2013-09-30
CL2013000682A1 (en) 2013-11-08
NZ608031A (en) 2015-01-30
EP2616471A1 (en) 2013-07-24
PT2616471E (en) 2015-04-20
CA2811005A1 (en) 2012-03-22
EP2616471B1 (en) 2014-12-31
MX2013002851A (en) 2013-05-28
CO6710916A2 (en) 2013-07-15
WO2012037141A1 (en) 2012-03-22
TW201219401A (en) 2012-05-16
CN103328481A (en) 2013-09-25
ES2536078T3 (en) 2015-05-20
BR112013006131A2 (en) 2016-06-07
US20120065200A1 (en) 2012-03-15

Similar Documents

Publication Publication Date Title
HK1213769A1 (en) Arginase inhibitors and methods of use thereof
EP2616442B8 (en) Inhibitors of pi3k-delta and methods of their use and manufacture
IL222227A0 (en) Pyrazol - 4 - heterocyclyl-carboxamide compounds and methods of use
EP2678018A4 (en) Combination of kanase inhibitors and uses thereof
ZA201301795B (en) Inhibitors of notum pectinacetylesterase and methods of their use
EP2536756A4 (en) Hsa-related compositions and methods of use
EP2584897A4 (en) Resveratrol-containing compositions and methods of use
EP2539005A4 (en) Mouthpiece and methods of use of same
SG11201504022RA (en) Glutamase inhibitors and method of use
EP2571421A4 (en) Detection devices and related methods of use
ZA201207937B (en) Sarms and method of use thereof
EP2675471A4 (en) Hsa-related compositions and methods of use
EP2536283A4 (en) Phenyl-heteroaryl derivatives and methods of use thereof
ZA201401653B (en) Pyrazol-4yl-heterocyclyl-carboxamide compounds and methods of use
EP2579831A4 (en) Dispenser and methods of use
HK1201463A1 (en) Cd40l-specific tn3-derived scaffolds and methods of use thereof cd40l- tn3-
EP2596112A4 (en) Acetycysteine compositions and methods of use thereof
EP2464227A4 (en) Compounds and methods of use thereof
EP2536709A4 (en) Prolylhydroxylase inhibitors and methods of use
IL257069B (en) Inhibitors of apoptosis and uses thereof
EP2709999A4 (en) Quinazoline-7-ether compounds and methods of use
EP2611791A4 (en) Oligooxopiperazines and methods of making and using them
ZA201303757B (en) Benzoxazepines as inhibitors of mtor and methods of their use and manufacture
ZA201303855B (en) Benzoxazepines as inhibitors of p13k/m tor and methods of their use and manufacture
GB2478317B (en) Herbicidal composition and method of use thereof